In vitro and in vivo studies of ICE inhibitors

Journal of Cellular Biochemistry

Volumn 64, Issue 1, 1997, Pages 19-26

  Livingston, David J ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

apoptosis; cytokine; ICE; interleukin 1; programmed cell death; protease

Indexed keywords

INTERLEUKIN 1BETA CONVERTING ENZYME;

APOPTOSIS; ARTICLE; CELL DEATH; CELL TYPE; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEPSIS; STEM CELL;

ANIMALS; APOPTOSIS; CASPASE 1; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; CYTOKINES; FORECASTING; HUMANS;

RODENTIA;

EID: 0031044283     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199701)64:1<19::AID-JCB4>3.0.CO;2-2     Document Type: Article

References (52)

1. 2). Teratology 50:214-228.
2. Ator M (1994): Peptide and non-peptide inhibitors of interleukin-1β converting enzyme. Paper presented at Inflammatory Cytokine Antagonists - Targets, Strategies and Indications. Cambridge Healthtech Institute (Waltham, MA), Philadelphia, October.
3. Bamba T, Yoshioka U, Inoue H, Iwasaki Y, Hosoda S (1994): Serum levels of interleukin-1β and interleukin-6 in patients with chronic pancreatitis. J Gastroenterol 29:314-319.
4. Bataille R, Chappard D, Klein B (1992): The critical role of interleukin-6, interleukin-1β and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. Int J Clin Lab Res 21:283-287.
5. Casellas F, Papo M, Guarner F, Antolin M, Segura RM, Armengol JR, Malagelda J-R (1995): Intracolonic release in vivo of interleukin-1β in chronic ulcerative colitis. Clin Sci 89:521-526.
6. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van NK, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, Huebner K, Black RA (1992): Molecular cloning of the interleukin-1β converting enzyme. Science 256:97-100.
7. Dinarello CA, Wolff SM (1993): The role of interleukin-1 in disease. N Engl J Med 328:106-113.
8. Dolle RE, Hoyer D, Prasad CVC, Schmidt SJ, Helaszek CT, Miller RE, Ator MA (1994a): Aspartate-based peptide α-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1β converting enzyme. J Med Chem 37:563-564.
9. 3 amido nitrogens for enzyme-peptide inhibitor binding. J Med Chem 37:3863-3865.
10. Dolle RE, Singh J, Whipple D, Osifo IK, Speier G, Graybill TL, Gregory JS, Harris AL, Helaszek CT, Miller RE, Ator MA (1995): Aspartyl α((diphenylphosphinyl)-xy)methyl ketones as novel inhibitors of interleukin-1β converting enzyme: Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases. J Med Chem 38:220-222.
11. Enari M, Hug H, Nagata S (1995): Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-80.
12. Estrov Z, Black RA, Sleath PR, Harris D, Van Q, LaPushin R, Estey EH, Talpaz M (1995): Effect of interluekin-1β converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation. Blood 86:4594-4602.
13. Faucheu C, Diu A, Chan AWE, Blanchet A-M, Miossec C, Herve F, Collard-Dutilleul V, Gu Y, Aldape R, Lippke J, Rocher C, Su MS-S, Livingston DJ, Hercend T, Lalanne J-L (1995): A novel human protease similar to the interleukin-1β converting enzyme induces apoptosis in transfected cells. EMBO J 9:914-1922.
14. Fearnhead HO, Dinsdale D, Cohen GM (1995): An interleukin-1β-converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett 375:283-288.
15. Fernandes-Alnemri T, Litwack G, Alnemri ES (1994): CPP32, a novel human apopototic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 converting enzyme. J Biol Chem 269:30761-30764.
16. Fernandes-Alnemri T, Litwack G, Alnemri ES (1995a): Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease family. Cancer Res 55:2737-2742.
17. Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Salveson G, Earnshaw WC, Litwack G, Alnemri ES (1995b): Mch3, a novel apoptotic cysteine protease highly related to CPP32. Cancer Res 55:6045-6052.
18. Fisher CJJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TH, Rackow EC, Shapiro MJ, Greenman RL (1994): Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double blind, placebo-controlled trial. JAMA 271:1836-1843.
19. Fletcher DS, Agarwal L, Chapman KT, Chin J, Egger LA, Limjuco G, Luell S, Macintyre DE, Peterson EP, Thornberry NA, Kostura MJ (1995): A synthetic inhibitor of interleukin-1β-converting enzyme prevents endotoxin-induced interleukin-1β production in vitro and in vivo. J Interferon Cytokine Res 15:243-248.
20. Gagliardini V, Fernandez PA, Lee RK, Drexier HC, Rotello RJ, Fishman MC, Yuan J (1994): Prevention of vertebrate neuronal death by the crmA gene. Science 263:826-828.
21. Geiger T, Towbin H, Cosenti-Vargas A, Zingle O, Arnold J, Rordorf C, Glatt M, Vosbeck K (1993): Neutralization of interleukin-1β activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin Exp Rheum 11:515-522.
22. Graybill TL, Dolle RE, Helaszek CT, Miller RE, Ator MA (1994): Preparation and evaluation of peptidic aspartyl hemiacetals as reversible inhibitors of interleukin-1 beta converting enzyme (ICE). Int J Pept Protein Res: 44: 173-82.
23. Goldring M (1992): Degradation of articular cartilage in culture: Regulatory factors. In Woessner JF Jr, Howell DS (eds): "Joint Cartilage Degradation: Basic and Clinical Aspects." New York: Marcel Dekker, pp 281-345.
24. Holden RJ, Mooney PA (1995): Interleukin-1β: A common cause of Alzheimer's disease and diabetes mellitus. Med Hypoth 45:559-571.
25. Howard AD, Kostura MJ, Thornberry NA, Ding, GJ, Limjuco G, Weidner J, Salley JP, Hogguist KA, Chaplin DD, Mumford RA, Schmidt JA, Tocci MJ (1991): IL-1 converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-kDa IL-1a. J Immunol 147:2964-2969.
26. Ku G, Faust T, Lauffer LL, Livingston DJ, Harding MW (1996): Irreversible inhibitors of interleukin-1β converting enzyme block IL-1β and IL-1α release and progression of type II collagen-induced arthritis in mice. Cytokine 8:377-386.
27. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS-S, Flavell RA (1995): Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000-2003.
28. Kumar S, Harvey NL (1995): Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett 375:169-173.
29. Lebsack ME, Paul CC, Martindale JJ, Catalano MA(1993): A dose- and regimen-ranging study of IL-1 receptor antagonist in patients with rheumatoid arthritis. Arthrit Rhemat 36:S39.
30. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardell S, Wei F-Y, Wong W, Kamen R, Seshadri T (1995): Mice deficient in interleukin-1β converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401-411.
31. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D (1989): Role of interleukin 1 in inflammatory bowel disease -Enhanced production during active disease. Gut 31:686-689.
32. Miller BE, Krasney PA, Gauvin DM, Holbrook KB, Koonz DJ, Abruzzese RV, Miller RE, Pagani KA, Dolle RE, Ator MA, Gilman SC (1995): Inhibition of mature IL-1β production in murine macrophages and a murine model of inflammation by WIN 67694, an inhibitor of IL-1β converting enzyme. J Immunol 154:1331-1338.
33. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J (1993): Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-660.
34. Mjalii AMM, Chapman KT, MacCoss M, Thornberry NA (1993): Phenylalkyl ketones as potent reversible inhibitors of interleukin-1β converting enzyme. Bioorg Med Chem Lett 3:2639-2692.
35. Mjalli AMM, Chapman KT, MacCoss M, Thornberry NA, Peterson EP (1994): Activated ketones as potent reversible inhibitors of interleukin-1β converting enzyme. Bioorg Med Chem Lett 4:1965-1968.
36. Mullican MD, Lauffer DJ, Gillespie RJ, Matharu SS, Kay D, Porritt GM, Evans PL, Golec JMC, Murcko MA, Loung Y-P, Raybuck SA, Livingston DJ (1994): The synthesis and evaluation of peptidyl aspartyl aldehydes as inhibitors of ICE. Bioorg Med Chem Lett 4:2359-2364.
37. Nicholson, DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK (1995): Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
38. Norman JG, Franz MG, Fink GS, Messina J, Fabri PJ, Gower WR, Carrey LC (1995): Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 221:625-634.
39. Prasad CVC, Prouty CP, Hoyer D, Ross TM, Salvino JM, Awad M, Graybill TL, Schmidt SJ, Osifo IK, Dolle RE, Helaszek CT, Miller RE, Ator MA (1995): Structural and stereochemical requirements of the time-dependent inactivators of the interleukin-1β converting enzyme. Bioorg Med Chem Lett 5:315-318.
40. Revesz L, Briswalter C, Heng R, Leutwiler A, Mueller R, Wuethrich H-J (1994): Synthesis of P1 aspartate-based peptide acyloxymethyl and fluoromethyl ketones as inhibitors of interleukin-1β converting enzyme. Tet Lett 35:9693-9696.
41. Shaw E (1990): Cysteinyl proteinases and their selective inactivation. Adv Enz 63:271-347.
42. Singer II, Scott S, Chin J, Bayne EK, Limjuco G, Weidner J, Miller DK, Chapman K, Kostura MJ (1995): The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immunoelectron microscopy. J Exp Med 182:1447-1459.
43. Sleath PR, Hendrickson RC, Kronheim SR, March CJ, Black RA (1990): Substrate specificity of the protease that processes human interleukin-1β. J Biol Chem 265: 14526-14528.
44. Smith RA, Copp LJ, Coles PJ, Pauls HW, Robinson VJ, Spencer RW, Heard SB, Krantz A (1988): New inhibitors of cysteine proteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge strategy. J Am Chem Soc 110:4429-4431.
45. Thornberry NA (1994): Interleukin-1β converting enzyme. Methods Enz 244:615-631.
46. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Faju SM, Rolando AM, Salley JP, Yamin T-T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, Tocci MJ (1992): A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768-774.
47. Thornberry NA, Peterson EP, Zhao JJ, Howard AD, Griffin PR, Chapman KT (1994): Inactivation of interleukin-1β converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry 33:3934-3940.
48. van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB (1995): Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Arthrit Rheum 38:164-172.
49. 2 homodimer. Cell 78:343-352.
50. Wang L, Miura M, Bergeron L, Zhu H, Yuan J (1994): Ich-1, an Ice/Ced-3 related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739-750.
51. Wilson KP, Black JF, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA, Livingston DJ (1994): Structure and mechanism of interleukin-1β converting enzyme. Nature 370: 270-253.
52. Zhu H, Fearnhead HO, Cohen GM (1995): An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP. 1 cells. FEBS Lett 374:303-308.